JPRN-UMIN000011007已完成3 期
The randomized controlled trial of the efficacy of mecobalamin and lafutidine after goshajinkigan administered in breast cancer patients with chemotherapy-induced peripheral neuropathy. - The efficacy of mecobalamin and lafutidine after goshajinkigan administered in breast cancer patients with chemotherapy-induced peripheral neuropathy.
Department of breast and endocrine surgery, Meiwa Hospital0 个研究点目标入组 35 人开始时间: 2013年6月19日最近更新:
适应症
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- Female
入选标准
- 未提供
排除标准
- •1)not goshajinkigan administered 2)with severe complications (such as liver failure, renal failure, heart failure) 3)with history of allergy 4)alredy adminstered with Goshajinkigan, Mecobalamin or Lafutidine. 5)with peripheral neuropathy for other cause (such as diabetes) 6)receiving drugs to influence peripheral neuropathy 7)doctore's decision not to be registered to this study
研究者
相似试验
已完成
3 期
The randomized controlled trial of the efficacy of goshajinkigan, mecobalamin and lafutidine in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000010969Department of breast and endocrine surgery, Meiwa Hospital50
已完成
3 期
The randomized controlled trial of the efficacy of goshajinkigan and lafutidine after mecobalamin administered in breast cancer patients with chemotherapy-induced peripheral neuropathy.chemotherapy-induced peripheral neuropathyJPRN-UMIN000010988Department of breast and endocrine surgery, Meiwa Hospital35
已完成
不适用
The randomized controlled trial on the efficacy of mobile-app delivered cognitive behavioral therapy for insomniaInsomniaJPRN-UMIN000023999europsychiatric Research Institute40
已完成
不适用
The randomized controlled trial on the efficacy of cognitive behavior therapy for insomniaJPRN-UMIN000014297Department of Psychophysiology, National Institute of Mental Health, National Center of Neurology & Psychiatry60
尚未招募
1 期
A randomized controlled trial for the efficacy of Dao-Yin in the prevention and controlling novel coronavirus pneumonia (COVID-19)ITMCTR2000003033Yueyang Hospital of Integrated Traditional Chinese and Western Medicine, Shanghai University of Traditional Chinese Medicine,